| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 200 | 96 | 9 | 8 | 4 | 4 | 9 | 12 | 4 | 11 | 3 | 3 | 7 | 2 | 5 | 4 | 10 | 5 | 5 | 8 | 9 | 16 | 9 | 7 | 5 | 7 | 3 | 3 | 3 | 5 | 6 | 8 | 11 |
| Expenses | 146 | 79 | 22 | 51 | 44 | 23 | 30 | 34 | 16 | 27 | 28 | 23 | 45 | 29 | 37 | 24 | 25 | 26 | 55 | 34 | 32 | 27 | 49 | 33 | 32 | 55 | 41 | 45 | 53 | 81 | 106 | 52 | 136 |
| EBITDA | 54 | 17 | -13 | -42 | -39 | -19 | -22 | -22 | -12 | -15 | -25 | -20 | -38 | -27 | -32 | -20 | -15 | -22 | -49 | -26 | -22 | -11 | -40 | -26 | -27 | -48 | -38 | -43 | -50 | -76 | -101 | -44 | -125 |
| Operating Profit % | 24 % | 11 % | -936 % | -2,025 % | -2,635 % | -1,517 % | -999 % | -290 % | -994 % | -196 % | -1,764 % | -1,383 % | -2,118 % | -2,341 % | -733 % | -467 % | -595 % | -494 % | -1,720 % | -1,208 % | -737 % | -768 % | -1,885 % | -1,267 % | -3,023 % | -2,032 % | -2,435 % | -2,981 % | -2,714 % | -8,671 % | -3,678 % | -3,331 % | -3,711 % |
| Depreciation | 6 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | 47 | 11 | -14 | -44 | -40 | -20 | -23 | -23 | -13 | -17 | -26 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -28 | -28 | -50 | -39 | -44 | -52 | -77 | -102 | -46 | -128 |
| Tax | 21 | 7 | 0 | -4 | -14 | -0 | 0 | 2 | -3 | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 26 | 4 | -14 | -39 | -26 | -20 | -23 | -26 | -11 | -16 | -24 | -22 | -39 | -28 | -34 | -21 | -16 | -23 | -51 | -28 | -24 | -13 | -42 | -27 | -28 | -50 | -39 | -44 | -52 | -77 | -102 | -46 | -128 |
| EPS in ₹ | 2.04 | 0.30 | -1.13 | -3.10 | -2.05 | -1.56 | -1.79 | -2.01 | -0.82 | -1.23 | -1.92 | -1.70 | -3.08 | -2.22 | -2.50 | -1.63 | -1.12 | -1.51 | -2.90 | -1.17 | -1.10 | -0.58 | -1.92 | -1.22 | -1.29 | -2.27 | -1.79 | -2.02 | -2.36 | -3.48 | -4.55 | -2.02 | -4.84 |
Suven Life Sciences
Suven Life Sciences
318.40
+0.60
(0.19%)
Market Cap
8,396.86 Cr
PE Ratio
-25.57
Volume
4,86,776.00
Day High - Low
324.25 - 312.00
52W High-Low
371.00 - 124.11
Q1 Quarterly Results are out. Check out the updated financials8 hrs ago
Show All
Key Fundamentals
Market Cap
8,396.86 Cr
EPS
-12.13
PE Ratio
-25.57
PB Ratio
13.16
Book Value
24.23
EBITDA
-270.60
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
-46.73
Debt to Equity
0.02
Actual
Company News
View All News
Suven Life Sciences reported a consolidated net loss of ₹1,276.10 crore for Q1FY27, driven by ₹1,238.31 crore in R&D expenses. Revenue rose 90% YoY to ₹35.66 crore as clinical trials progress.
Suven Life Sciences Limited filed its Business Responsibility and Sustainability Report for FY26, highlighting that exports contribute 70% of total turnover. The report details employee welfare, safety protocols, and environmental metrics.
Suven Life Sciences reports FY26 standalone loss of ₹5,486.28 lakhs, raises ₹85,764.02 lakhs via preferential issue, and schedules 37th AGM on August 25, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
403.70 | #1 16,296.12 | 73.13 | #1 3,809.40 | 2.56 | 317 | -110.38 | 44.02 | |
554.45 | 13,359.71 | 33.18 | 3,582.50 | 21.58 | #1 401 | -0.17 | 65.86 | |
318.40 | #3 8,396.86 | #8 -25.57 | #8 21.00 | #4 19.32 | #9 -276 | #8 -147.77 | 52.84 | |
651.25 | 2,909.09 | 35.09 | 322.30 | 0.22 | 41 | 112.87 | 66.31 | |
22.69 | 335.66 | #1 30.48 | 54.19 | #1 431.27 | 11 | 189.80 | 49.95 | |
80.11 | 160.84 | 157.73 | 61.54 | 29.56 | 2 | #1 238.46 | 61.96 | |
62.92 | 148.15 | -8.45 | 733.54 | -9.05 | -21 | -35.54 | 57.82 | |
16.30 | 23.50 | 33.09 | 56.10 | -33.21 | 1 | -88.00 | 22.25 | |
21.75 | 15.43 | 152.20 | 1.82 | -13.33 | 0 | -380.00 | 45.78 |
Growth Rate
Revenue Growth
19.32 %
Net Income Growth
71.94 %
Cash Flow Change
-93.10 %
ROE
-68.03 %
ROCE
-68.29 %
EBITDA Margin (Avg.)
45.71 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 | 135 | 624 |
| Fixed Assets | 172 | 305 | 306 | 308 | 22 | 25 | 21 | 38 | 37 | 28 | 60 | 73 |
| Current Assets | 477 | 428 | 492 | 570 | 281 | 66 | 103 | 67 | 252 | 257 | 76 | 547 |
| Capital Work in Progress | 107 | 7 | 10 | 25 | 0 | 0 | 5 | 4 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 301 | 279 | 223 | 0 | 0 | 45 | 46 | 76 | 22 | 181 |
| Other Assets | 494 | 439 | 199 | 308 | 58 | 157 | 103 | 22 | 305 | 181 | 53 | 367 |
| Total Equity & Liabilities | 773 | 752 | 816 | 919 | 303 | 182 | 128 | 108 | 389 | 285 | 135 | 624 |
| Current Liabilities | 127 | 111 | 119 | 122 | 40 | 27 | 16 | 8 | 11 | 14 | 24 | 19 |
| Non Current Liabilities | 86 | 46 | 30 | 30 | 25 | 12 | 5 | 4 | 3 | 1 | 2 | 14 |
| Total Equity | 559 | 595 | 667 | 767 | 239 | 143 | 108 | 96 | 375 | 270 | 110 | 591 |
| Reserve & Surplus | 547 | 583 | 654 | 755 | 226 | 131 | 58 | 82 | 354 | 248 | 88 | 410 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 22 | 22 | 22 | 26 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 212 | -39 | -232 | 17 | -18 | 14 | -5 | -4 | 32 | -22 | -1 | -5 |
| Investing Activities | -110 | -39 | -311 | -1 | 30 | 146 | 56 | -22 | -248 | 94 | 155 | -462 |
| Operating Activities | 143 | 68 | 109 | 70 | -53 | -135 | -96 | -128 | -116 | -116 | -155 | -300 |
| Financing Activities | 179 | -68 | -30 | -52 | 5 | 3 | 35 | 146 | 396 | -1 | -1 | 757 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
| Promoter | 60.00 % | 60.00 % | 60.00 % | 60.00 % | 64.98 % | 64.98 % | 64.98 % | 64.98 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 69.57 % | 70.27 % | 70.27 % | 70.27 % | 70.27 % | 70.27 % | 67.43 % | 67.36 % | 67.36 % | 70.15 % | 70.08 % | 65.47 % | 65.47 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.50 % | 0.54 % | 0.46 % | 0.45 % | 0.34 % | 0.34 % | 0.25 % | 0.59 % | 0.56 % | 1.18 % | 1.07 % | 0.91 % | 0.57 % | 0.48 % | 0.48 % |
| DIIs | 0.21 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.13 % | 0.12 % | 0.11 % | 0.11 % | 0.08 % | 0.01 % | 0.12 % | 1.17 % | 1.17 % | 1.05 % | 1.06 % | 0.01 % | 0.02 % | 3.41 % | 3.39 % | 3.39 % | 4.62 % | 2.93 % | 2.73 % | 2.73 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.92 % | 34.22 % | 33.19 % | 33.24 % | 28.69 % | 29.02 % | 27.37 % | 27.43 % | 22.98 % | 23.00 % | 23.29 % | 24.38 % | 24.05 % | 22.29 % | 22.66 % | 22.15 % | 22.31 % | 24.04 % | 23.17 % | 22.24 % | 22.25 % | 22.29 % | 19.45 % | 21.37 % | 24.40 % | 24.40 % |
| Others | 5.87 % | 5.76 % | 6.79 % | 6.74 % | 6.31 % | 5.98 % | 7.52 % | 7.48 % | 7.34 % | 7.32 % | 7.06 % | 5.54 % | 5.72 % | 6.51 % | 5.46 % | 6.19 % | 6.04 % | 5.44 % | 5.95 % | 6.37 % | 5.82 % | 5.90 % | 4.87 % | 5.06 % | 6.92 % | 6.92 % |
| No of Share Holders | 77,650 | 86,008 | 81,475 | 80,195 | 81,062 | 81,038 | 80,116 | 80,536 | 80,838 | 78,634 | 76,291 | 80,953 | 74,003 | 68,959 | 66,116 | 63,975 | 63,537 | 64,603 | 66,159 | 65,574 | 64,921 | 64,381 | 64,037 | 66,791 | 66,647 | 66,647 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1 | 1.5 | 1.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 12.85 | 0.57 | 7.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Aug 2026 |  Annual General Meeting | NA | 25 Aug 2026 | 215.25 | 318.20 |
| 18 Oct 2022 |  Rights | 1:2 | 17 Oct 2022 | 64.87 | 68.00 |
| 02 Aug 2024 | Annual General Meeting | NA | 02 Aug 2024 | 113.45 | 143.05 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 131.40 | 121.40 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 133.25 | 122.20 |
| 13 May 2025 | Quarterly Result Announcement | NA | 13 May 2025 | 131.05 | 152.80 |
| 05 Jun 2025 |  Extraordinary General Meeting | NA | 05 Jun 2025 | 152.80 | 234.35 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 268.80 | 233.20 |
| 22 Aug 2025 | Annual General Meeting | NA | 22 Aug 2025 | 152.80 | 234.35 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 197.45 | 187.15 |
| 29 Jan 2026 | Quarterly Result Announcement | NA | 29 Jan 2026 | 135.25 | 132.00 |
| 13 May 2026 | Quarterly Result Announcement | NA | 13 May 2026 | 205.65 | 215.25 |
| 06 Aug 2026 | Quarterly Result Announcement | NA | 06 Aug 2026 | 313.25 | 327.80 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 hrs ago
19 hrs agoBoard Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30 20261 day ago
1 day agoUn-Audited Financial Results For The Quarter Ended 30Th June 20261 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication7 days ago
7 days agoBoard Meeting Intimation for Consideration Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 20268 days ago
8 days agoLetter To Shareholders Regarding Annual Report FY 2025-268 days ago
8 days agoBusiness Responsibility and Sustainability Reporting (BRSR)8 days ago
8 days agoNotice Of 37Th Annual General Meeting (AGM) Of The Company8 days ago
8 days agoReg. 34 (1) Annual Report.8 days ago
8 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 20, 2026
Jul 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 14, 2026
Jul 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 14, 2026
Jul 14, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 10, 2026
Jul 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Jul 08, 2026Revised Outcome Of The Meeting Of Board Of Directors- Incorporation Of Wholly Owned Subsidiary (WOS) In SingaporeJul 08, 2026
Jul 08, 2026Incorporation Of Wholly Owned Subsidiary (WOS) In SingaporeJul 08, 2026
Jul 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 08, 2026
Jul 08, 2026Announcement under Regulation 30 (LODR)-AllotmentJul 08, 2026
Jul 08, 2026Board Meeting Outcome for Outcome Of Board MeetingJul 08, 2026
Jul 08, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 22, 2026
Jun 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 22, 2026
Jun 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 17, 2026
Jun 17, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 12, 2026
Jun 12, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 04, 2026
Jun 04, 2026Rectification Order For Assesment Year 2020-21May 29, 2026
May 29, 2026Clarification On Volume Movement LetterMay 19, 2026
May 19, 2026Clarification sought from Suven Life Sciences LtdMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2026
May 14, 2026Grant Of Stock OptionsMay 13, 2026
May 13, 2026Outcome Of The Meeting Of Board Of Directors Held On May 13 2026May 13, 2026
May 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Of Suven Life Sciences Limited Held On May 13 2026May 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 12, 2026
May 12, 2026Board Meeting Intimation for Consideration Of Audited Financial Results (Standalone And Consoldiated) For The Quarter And Financial Year Ended 31 March 2026.May 06, 2026
May 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 23, 2026
Apr 23, 2026Clarification On Price MovementApr 08, 2026
Apr 08, 2026Clarification sought from Suven Life Sciences LtdApr 07, 2026
Apr 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 09, 2026
Mar 09, 2026Board Meeting Outcome for ALLOTMENT OF 31768764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASISMar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-AllotmentMar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2026
Feb 19, 2026Clarification On Price MovementFeb 06, 2026
Feb 06, 2026Clarification sought from Suven Life Sciences LtdFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2026
Jan 30, 2026Appointment of Company Secretary and Compliance OfficerJan 29, 2026
Jan 29, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | -223 | -0.01% | -0.01% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.13% | |
 Quant Small Cap Fund Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 52.62
ATR(14)
Less Volatile 18.17
STOCH(9,6)
Neutral 48.36
STOCH RSI(14)
Neutral 50.83
MACD(12,26)
Bearish -2.70
ADX(14)
Weak Trend 20.23
UO(9)
Bearish 57.55
ROC(12)
Downtrend And Accelerating -6.65
WillR(14)
Neutral -49.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
